Joint Formulary & PAD

Vortioxetine - Depression

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green (see narrative)
Formulations :
  • Tablets
Associated Icons :
Restrictions / Comments :
Important

For treating major depressive episodes in line with NICE TA367.

PAD Profile

ChemicalSubstance :
Vortioxetine
Indication :
Depression
Group Name :
Keywords :
antidepressants, major depressive episodes
Brand Names Include :
Brintellix
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
4

Other Indications

Below are listed other indications that Vortioxetine is used to treat.

  • No records returned.

Committee Recommendations (1)

The PCN supports the use of vortioxetine for treating major depressive episodes in line with NICE TA367 (November 2015). Vortioxetine will be considered GREEN on the traffic light system Note - The Mood Hive and associated local depression and anxiety treatment guidelines have been removed from PAD. Updated guidelines and resources for treating and managing depression in adults are being developed by Surrey & Borders Partnership. For current advice, in line with NICE guidance, please see the Clinical Knowledge Summaries.